Source:http://linkedlifedata.com/resource/pubmed/id/21079232
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-11-16
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1539-3704
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
16
|
pubmed:volume |
153
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
688; author reply 689-90
|
pubmed:meshHeading |
pubmed-meshheading:21079232-Anticoagulants,
pubmed-meshheading:21079232-Drug Administration Schedule,
pubmed-meshheading:21079232-Enoxaparin,
pubmed-meshheading:21079232-Hemorrhage,
pubmed-meshheading:21079232-Humans,
pubmed-meshheading:21079232-Immobilization,
pubmed-meshheading:21079232-Risk Factors,
pubmed-meshheading:21079232-Venous Thromboembolism
|
pubmed:year |
2010
|
pubmed:articleTitle |
Extended-duration venous thromboembolism prophylaxis for medical patients.
|
pubmed:publicationType |
Letter,
Comment
|